Want to see TSE:NRX full AI Analyst Report?

NurExone Biologic (NRX) Revenue

13 Followers

NurExone Biologic Revenue

NurExone Biologic had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Mar 31, 2026, NurExone Biologic had annual revenue of 0.00 with ― growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

C$0

Employees

Market Cap

C$49.76M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	―	―	―
Mar 31, 2025	―	―	―
Mar 31, 2024	―	―	―
Dec 31, 2022	―	―	―
Mar 31, 2022	―	―	―